HTRF - Her3 phospho-y1289 kit - 500 tests 1 Kit
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
The phospho-HER3 (Tyr1289) assay is designed for the robust quantification of HER3 (Erbb3) modulation when phosphorylated on Tyr1289, an indicator of many types of cancer pathologies. Overexpression of HER3, or human epidermoid receptor 3/ ErbB3, is considered as an indicator for a poor prognosis in human breast cancer. Heterodimerization of HER3 with HER2 is associated with an increase in the aggressiveness of a breast cancer. HER3 is also been found to be involved in prostate, gastric, colon, or other carcinomas. This makes HER3 a key target for anti-cancer therapies.
Garantie
Garantie 0 Mois
Description
The phospho-HER3 (Tyr1289) assay is designed for the robust quantification of HER3 (Erbb3) modulation when phosphorylated on Tyr1289, an indicator of many types of cancer pathologies. Overexpression of HER3, or human epidermoid receptor 3/ ErbB3, is considered as an indicator for a poor prognosis in human breast cancer. Heterodimerization of HER3 with HER2 is associated with an increase in the aggressiveness of a breast cancer. HER3 is also been found to be involved in prostate, gastric, colon, or other carcinomas. This makes HER3 a key target for anti-cancer therapies.
Caractéristiques
- Marque
- REVVITY
- Libellé produit fabricant
- Phospho-HER3 (Tyr1289) cellular kit, 500 Tests
- Référence distributeur
- 64HR3PEG
- Référence fabricant
- 64HR3PEG
- Fournisseur
- REVVITY
- Reprise en cas d’erreur client
- non
- Lieu de fabrication
- France
- Lieu de stockage
- France
- Domaine de recherche
- biologie cellulaire
- Délai de péremption à la date de livraison
- 6 mois
- Soumis à carboglace
- oui
- Soumis à réglementation
- non
- Température de conservation (°C)
- -80 à -60 °C
- Type d’application
- détection Phosphoprotéines/Voies de signalisation- Alternative ELISA/WB - Sans lavage
- Vendu par
- 1 kit
- Quantité
- N/A
- Nomenclature Nacres
- NA.84
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA84
- Nomenclature CNRS
- NA84
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD11AOOO